Our research focus is to enhance immune resilience against inflammation, cellular senescence, and age-related diseases. We have demonstrated that mitochondrial dysfunction in T cells mimics aging and leads to widespread health deterioration (Science, 2020). We have also identified molecular mechanisms by which aged T cells contribute to age-related diseases (Cell Metabolism 2021; Nature Rev Immunol, 2022). Additionally, we propose therapies to reverse aortic aneurysms and improve mitochondrial metabolism (Circulation, 2021; Atherosclerosis, Thrombosis Vascular Biology, 2022; Br J Pharmacol.